Generic formulations of psychotropic medications and treatment response.
作者信息
Bhat Venkat, Margolese Howard C
机构信息
From the Department of Psychiatry, McGill University, Montreal, Que., Canada.
出版信息
J Psychiatry Neurosci. 2017 Mar;42(2):E3-E4. doi: 10.1503/jpn.160004.
Abstract
摘要
相似文献
1
Generic formulations of psychotropic medications and treatment response.精神药物的通用制剂与治疗反应。
J Psychiatry Neurosci. 2017 Mar;42(2):E3-E4. doi: 10.1503/jpn.160004.
2
[Venlafaxine-induced delirium mediated by high doses].[高剂量介导的文拉法辛所致谵妄]
Rev Neurol. 2015 May 16;60(10):475-7.
3
Differences in generic sertraline for children: real or artefact from cost containing to clinical quality of generics use.儿童用舍曲林仿制药的差异：从成本考量到仿制药临床质量的真实情况还是人为因素。
Eur J Clin Pharmacol. 2006 Dec;62(12):1083-5. doi: 10.1007/s00228-006-0207-y. Epub 2006 Nov 7.
4
Clarification regarding generic substitution for psychotropic drugs.关于精神药物通用名替换的说明。
CNS Spectr. 2009 Dec;14(12):709-10. doi: 10.1017/s1092852900023968.
5
Generic substitution for psychotropic drugs.精神药物的通用名替换
CNS Spectr. 2009 Sep;14(9 Suppl Q and A Forum):1-7. doi: 10.1017/s1092852900024706.
6
[Psychosis, Intoxication or Serotonin Syndrome? - A 20-Year Old Male with Ziprasidone und Sertraline].[精神病、中毒还是血清素综合征？——一名20岁服用齐拉西酮和舍曲林的男性]
Psychiatr Prax. 2017 Nov;44(8):473-475. doi: 10.1055/s-0043-114869. Epub 2017 Jul 19.
7
Comment: economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder.评论：在重度抑郁症患者中，用一种替代性通用型选择性5-羟色胺再摄取抑制剂对一种品牌选择性5-羟色胺再摄取抑制剂进行治疗性替代的经济影响。
Ann Pharmacother. 2011 Sep;45(9):1169-70. doi: 10.1345/aph.1P482a. Epub 2011 Aug 18.
8
Why is mechanism of action important in antidepressant treatment?抗抑郁治疗中作用机制为何重要？
J Clin Psychiatry. 2016 May;77(5):e603. doi: 10.4088/JCP.14052cc3c.
9
[Generic drugs: what do patients really know about them?].[通用药物：患者对它们究竟了解多少？]
Encephale. 2014 Sep;40(4):351-2. doi: 10.1016/j.encep.2014.03.001. Epub 2014 May 10.
10
When is a "generic" medication not really a generic?一种“仿制药”在什么时候并非真正意义上的仿制药？
J Psychosoc Nurs Ment Health Serv. 2010 Feb;48(2):13-6. doi: 10.3928/02793695-20100108-98.
本文引用的文献
1
The Impact of Generic Substitution on Health and Economic Outcomes: A Systematic Review.仿制药替代对健康和经济结果的影响：一项系统评价
Appl Health Econ Health Policy. 2015 Aug;13 Suppl 1(Suppl 1):S21-33. doi: 10.1007/s40258-014-0147-0.
2
Generic Olanzapine Substitution in Patients With Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching.精神分裂症患者中通用型奥氮平的替代：换药后血清浓度及治疗反应评估
Ther Drug Monit. 2015 Dec;37(6):827-30. doi: 10.1097/FTD.0000000000000211.
3
Off-patent generic medicines vs. off-patent brand medicines for six reference drugs: a retrospective claims data study from five local healthcare units in the Lombardy Region of Italy.非专利通用药物与六种参照药物的非专利品牌药物对比：来自意大利伦巴第大区五个地方医疗机构的回顾性理赔数据研究。
PLoS One. 2013 Dec 18;8(12):e82990. doi: 10.1371/journal.pone.0082990. eCollection 2013.
4
The comparison of brand-name and generic formulations of venlafaxine: a therapeutic drug monitoring analysis.文拉法辛品牌药与仿制药的比较：治疗药物监测分析
Ther Drug Monit. 2014 Apr;36(2):269-72. doi: 10.1097/FTD.0000000000000008.
5
Mental state deterioration after switching from brand-name to generic olanzapine in an adolescent with bipolar affective disorder, autism and intellectual disability: a case study.双相情感障碍、自闭症和智力残疾青少年从奥氮平原研药换用仿制药后精神状态恶化：1 例病例研究。
BMC Psychiatry. 2013 Oct 4;13:244. doi: 10.1186/1471-244X-13-244.
6
Rational use of generic psychotropic drugs.合理使用非专利精神药物。
CNS Drugs. 2013 May;27(5):353-65. doi: 10.1007/s40263-013-0045-2.
7
Approvable generic carbamazepine formulations may not be bioequivalent in target patient populations.可批准的卡马西平仿制药制剂在目标患者群体中可能没有生物等效性。
Int J Clin Pharmacol Ther. 2013 Jun;51(6):525-8. doi: 10.5414/CP201845.
8
An analysis of the slowdown in growth of spending for psychiatric drugs, 1986-2008.1986-2008 年精神科药物支出增长放缓的分析。
Psychiatr Serv. 2012 Jan;63(1):13-8. doi: 10.1176/appi.ps.201100564.
9
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.AGNP 精神科治疗药物监测共识指南：2011 年更新版。
Pharmacopsychiatry. 2011 Sep;44(6):195-235. doi: 10.1055/s-0031-1286287. Epub 2011 Sep 27.
10
Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder.治疗性替代品牌选择性 5-羟色胺再摄取抑制剂与替代通用选择性 5-羟色胺再摄取抑制剂治疗重度抑郁症患者的经济影响。
Ann Pharmacother. 2011 Apr;45(4):441-51. doi: 10.1345/aph.1P482. Epub 2011 Mar 17.
Zotero 插件